We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Eye Changes Found in Alzheimer's Patients

By Biotechdaily staff writers
Posted on 07 May 2003
Researchers have found that amyloid-beta (A-beta), the protein that forms plaques in the brains of Alzheimer's patients, can also be detected in the lens of the eye. More...
This finding, which may lead to an early diagnostic test for Alzheimer's, was reported in the April 12, 2003, issue of The Lancet.

While A-beta was identified in the lenses of elderly individuals with and without Alzheimer's disease, an unusual pattern of amyloid deposits was found only in the lenses of Alzheimer's patients. Researchers examined samples of brain tissue and lenses taken from nine people who had died from Alzheimer's and from eight controls who died from other neurodegenerative disorders. They also tested samples of aqueous humor taken from healthy volunteer patients having cataracts removed. A distinctive pattern of deposits was found in the outer, peripheral portion of only the lenses from Alzheimer's patients. The researchers noted that people with Down syndrome, who develop Alzheimer's at an early age, are also prone to early-onset cataracts.

"One of the most exciting aspects of this finding is the fact that these deposits are associated with a type of cataract seen rarely in the general population,” said Leo T. Chylack, Jr., M.D., director of the Center for Ophthalmic Research at the Brigham and Women's Hospital (BWH, Boston, MA, USA) and one of the principal investigators. "These cataracts do not block vision and can only be seen when the pupil is dilated widely. If the association of these deposits with Alzheimer's holds up in future studies, it would be very simple to develop a noninvasive test of disease progression.”




Related Links:
Brigham and Women's

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Urine Analyzer
respons® UDS100
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.